Compound information
- Natural Products
- ZC1218019
- Molecular Formula
- C22H26N2O6
- Molecular Weight
- 414.179086552 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[[(2S)-2-(benzyloxycarbonylamino)-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
- InChI
- InChI=1S/C22H26N2O6/c1-14(2)19(24-22(29)30-13-16-6-4-3-5-7-16)20(26)23-18(21(27)28)12-15-8-10-17(25)11-9-15/h3-11,14,18-19,25H,12-13H2,1-2H3,(H,23,26)(H,24,29)(H,27,28)/t18-,19+/m1/s1
- InChI Key
- YPLGNDYBRBVBCT-MOPGFXCFSA-N
- SMILES
- CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O
- Source
- ZINC000004321885
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 124.96 Å2 | LogP | 2.529 |
LogS | -3.161 | LogD | 2.425 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.833 |
HIA | 0.584 | F20 % | 0.991 |
F30 % | 0.953 | Caco-2 | -6.286 |
MDCK | -5.579 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.056 | PPB | 75.017 |
VD | 0.357 | Fu | 0.86 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.698 |
CYP2A6 substrate | 0.326 | CYP2B6 substrate | 0.419 |
CYP2C19 inhibitor | 0.036 | CYP2C19 substrate | 0.714 |
CYP2C8 substrate | 0.848 | CYP2C9 inhibitor | 0.146 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.096 |
CYP2D6 substrate | 0.29 | CYP2E1 substrate | 0.369 |
CYP3A4 inhibitor | 0.025 | CYP3A4 substrate | 0.646 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.952 | CL | 1.819 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.006 | Hepatotoxicity | 0.559 |
Mutagenicity | 0.122 | Rat Oral Acute Toxicity | 0.098 |
FDAMDD | 0.019 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.004 |
Eye Irritation | 0.083 | Respiratory Toxicity | 0.0 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.314 | IGC50 | 2.26 |
LC50FM | 3.682 | LC50DM | 4.265 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.422 | NR-AR-LBD | 0.327 |
NR-AhR | 0.006 | NR-Aromatase | 0.031 |
NR-ER | 0.437 | NR-ER-LBD | 0.516 |
NR-PPAR-gamma | 0.61 | SR-ARE | 0.193 |
SR-ATAD5 | 0.333 | SR-HSE | 0.145 |
SR-MMP | 0.048 | SR-p53 | 0.079 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.